PolyPid Change In Cash from 2010 to 2026

PYPD Stock  USD 4.25  0.03  0.71%   
PolyPid's Change In Cash is decreasing over the years with slightly volatile fluctuation. Overall, Change In Cash is projected to go to about -8.8 M this year. During the period from 2010 to 2026 PolyPid Change In Cash annual values regression line had geometric mean of  2,044,370 and mean square error of 27.7 T. View All Fundamentals
 
Change In Cash  
First Reported
2016-09-30
Previous Quarter
-7.8 M
Current Value
-3.3 M
Quarterly Volatility
20.7 M
 
Covid
 
Interest Hikes
Check PolyPid financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PolyPid's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2 M, Interest Expense of 650.8 K or Selling General Administrative of 5.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.79. PolyPid financial statements analysis is a perfect complement when working with PolyPid Valuation or Volatility modules.
  
Build AI portfolio with PolyPid Stock
Check out the analysis of PolyPid Correlation against competitors.
For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.
Analyzing PolyPid's Change In Cash over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Change In Cash has evolved provides context for assessing PolyPid's current valuation and future prospects.

Latest PolyPid's Change In Cash Growth Pattern

Below is the plot of the Change In Cash of PolyPid over the last few years. It is PolyPid's Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PolyPid's overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Slightly volatile
   Change In Cash   
       Timeline  

PolyPid Change In Cash Regression Statistics

Arithmetic Mean8,629
Geometric Mean2,044,370
Coefficient Of Variation61,401
Mean Deviation3,786,950
Median351,000
Standard Deviation5,298,525
Sample Variance28.1T
Range19.4M
R-Value(0.27)
Mean Square Error27.7T
R-Squared0.07
Significance0.29
Slope(285,817)
Total Sum of Squares449.2T

PolyPid Change In Cash History

2026-8.8 M
2025-9.2 M
202410.2 M
2023-3.5 M
2022-1.2 M
20215.5 M
2020410 K

About PolyPid Financial Statements

PolyPid stakeholders use historical fundamental indicators, such as PolyPid's Change In Cash, to determine how well the company is positioned to perform in the future. Although PolyPid investors may analyze each financial statement separately, they are all interrelated. For example, changes in PolyPid's assets and liabilities are reflected in the revenues and expenses on PolyPid's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PolyPid. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change In Cash-9.2 M-8.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:
Check out the analysis of PolyPid Correlation against competitors.
For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Will Biotechnology sector continue expanding? Could PolyPid diversify its offerings? Factors like these will boost the valuation of PolyPid. Anticipated expansion of PolyPid directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PolyPid data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(2.09)
Return On Assets
(0.87)
Return On Equity
(3.66)
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between PolyPid's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PolyPid should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, PolyPid's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.